The Duke Human Vaccine Institute (DHVI), located in Durham, North Carolina, was formed to support Duke University School of Medicine's efforts to develop vaccines and therapeutics for HIV and other emerging infections.
[1] In 1990, the Duke Human Vaccine Institute, located in Durham, North Carolina, was formed to support Duke University School of Medicine's interdisciplinary efforts to develop vaccines and therapeutics for HIV and other emerging infections.
DHVI received support from the Dean of the School of Medicine to recruit new faculty for HIV research and to apply for a Regional Center for Excellence in Emerging Infections and Biodefense grant from the National Institutes of Health (NIH) in 2002.
Completed in 2006, this building is designed to support basic research and to provide surge capacity in the event of a public health emergency.
Over the next 7 years (beginning in 2012), the Duke CHAVI-ID builds on CHAVI to improve HIV-1 vaccine design.